Skip to content

Effects of Exercise Behavior Modification on Plasma Adiponectin and Insulin Resistance in High Risk Subjects of Diabetes

Effects of Exercise Behavior Modification on Plasma Adiponectin and Insulin Resistance in High Risk Subjects of Diabetes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01136096
Enrollment
216
Registered
2010-06-03
Start date
2004-01-31
Completion date
2005-06-30
Last updated
2010-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Keywords

diabetes, physical activity, adiponectin, metabolic risks, exercise, primary prevention

Brief summary

Investigators hypothesized home-based exercise intervention was beneficial to those who have had diabetic risk factor for type 2 diabetes mellitus

Detailed description

This randomized clinical trial was designed to investigate whether a home-based exercise could improve adiponectin levels, exercise behavior and metabolic risk factors (insulin resistance, metabolic components and physical fitness) in subjects with at least a diabetic risk factor for type 2 diabetes mellitus. Participants were randomly allocated to either a control group or a home-based exercise group. All participants were evaluated for outcome measures at baseline, and at 3-month 6-month and 9-month follow-up after engaging in the intervention.

Interventions

BEHAVIORALPhysical activity promoting intervention

1. An interview with a physiotherapist 2. An exercise video specially designed by this study including warm-up, aerobic, cool-down and stretching exercises, and/or a simple exerciser to use at home 3. An individualized home-based exercise program based on the Health Belief Model and Transtheoretical Model 4. The daily record to check their body weight, exercise mode and duration 5. Proper diet, caloric intake calculation, metabolic risk factors and prevention of diabetes were taught and a guide book was provided that included all the above mentioned details 6. Telephone reminders of healthy lifestyle including the ways of overcoming barriers of regular exercise every 1 to 2 weeks for 3 months, 1-2 calls a month afterwards and no calls for the last month on a tapered off schedule

BEHAVIORALGeneral instruction and education

1. Oral instruction and written general education information about weight control, proper diet and regular exercise in a one-page education brochure that was similar to the way used in the outpatient clinic 2. Telephone reminders of healthy lifestyle every 1 to 2 weeks for 3 months, 1-2 calls a month afterwards and no calls for the last month on a tapered off schedule 3. Without individualized exercise program and interview with a physiotherapist

Sponsors

Department of Health, Executive Yuan, R.O.C. (Taiwan)
CollaboratorOTHER_GOV
National Taiwan University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* At least one of the following criteria as following: BMI \>=24 kg/m\*m, hypertension, dyslipidemia, fist-degree relatives of parents with type 2 diabetes, impaired glucose tolerance, gestational diabetes and delivering a babt weighing \>=4.0 kg * Ability of understanding Chinese or Taiwanese

Exclusion criteria

* Diabetes * Receiving treatment with insulin or oral hypoglycemic agents * Any other serious illness that prohibit them to undertake fitness evaluation

Design outcomes

Primary

MeasureTime frameDescription
Plasma adiponectin level in μg/mlNine months after the start of the interventionFasting blood samples were centrifuged to obtain plasma and then immediately stored at -20℃. Plasma adiponectin levels were then determined through enzyme-linked immunoassay (ELISA).
Exercise behaviorNine months after the start of the intervention1. Exercise self-efficacy: Measured by exercise self-efficacy questionnaire in score 2. Physical activity: Meausred by 7-day recall questionnaire in kcal/kg/day

Secondary

MeasureTime frameDescription
Physical fitnessThree, 6 and 9 months after the start of the intervention1. Body composition (kg/m\^2): Body mass index that was weight in kilograms divided by the square of height in meter 2. Flexibility (cm): Meausred by sit-and-reach test 3. Grip strength (Nm): Measured by Jamar handheld dynameter 4. Muscle endurance (times/min): Measured by sit-up test 5. Cardiopulmonary fitness (3-minute step test)
Dietary intakeThree, 6 and 9 months after the start of the interventionMeasured by 24-hour recall guestionnaire in kcal/kg/day
Insulin resistanceThree, 6 and 9 months after the start of the interventionplasma inulin level (μU/ml) meausred by AxSYM with HOMA-IR was caculated
Exercise behaviorThree and 6 months after the start of the intervention1. Exercise self-efficacy: Measured by exercise self-efficacy questionnaire in score 2. Physical activity: Meausred by 7-day recall questionnaire in kcal/kg/day
Plasma adiponectin level in μg/mlThree and 6 months after the start of the interventionFasting blood samples were centrifuged to obtain plasma and then immediately stored at -20℃. Plasma adiponectin levels were then determined through enzyme-linked immunoassay (ELISA)
Metabolic componentsThree, 6 and 9 months after the start of the intervention1. Waist circumference (cm) 2. Fasting blood samples were centrifuged to obtain plasma for plasma triglycerides (TG) and high-density lipoprotein (HDL) levels in mg/dl 3. Plasma fasting glucose (FG) levels were measured in mg/dl by using the glucose oxidase membrane/hydrogen peroxide electrode method with the Antsense II analyzer (Bayer-Sankyo Co., Tokyo, Japan) 4. Systolic blood pressure (SBP) and dystolic blood pressure (DBP) in mmHg

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026